4-[2-(4-Fluoro-phenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-4H-pyridine-1-carboxylic acid ethyl ester | 122454-73-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-[2-(4-Fluoro-phenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-4H-pyridine-1-carboxylic acid ethyl ester
• 英文别名: ethyl 4-[2-(4-fluorophenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-4H-pyridine-1-carboxylate
• CAS: 122454-73-3
• 化学式: C₂₀H₂₀FN₃O₂
• 分子量: 353.396
• InChiKey: XTCLENWUXYZHAW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  26
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  47.4
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-[2-(4-Fluoro-phenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-4H-pyridine-1-carboxylic acid ethyl ester 在 potassium tert-butylate 、 氧气 、 叔丁醇 作用下， 反应 19.0h， 以56%的产率得到2-(4-Fluorophenyl)-3-(4-pyridyl)-6,7-dihydro-[5H]-pyrrolo-[1,2-a]-imidazole
  参考文献：
  名称：

  Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase

  摘要：

  Members of three classes of pyridinylimidazoles bind with varying affinities to CSBP (p38) kinase which is a member of a stress-induced signal transduction pathway. Based upon SAR and protein homology modeling, the pharmacophore and three potential modes of binding to the enzyme are presented. For a subset of pyridinylimidazoles, binding is shown to correlate with inhibition of CSBP kinase activity, whereas no significant inhibition of PKA, PKC alpha and ERK kinase activity is observed. Copyright (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0968-0896(96)00212-x
• 作为产物：
  描述：

  2-氯代-4'-氟苯乙酮 以 二氯甲烷 、 氯仿 、 水 为溶剂， 反应 12.0h， 生成 4-[2-(4-Fluoro-phenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]-4H-pyridine-1-carboxylic acid ethyl ester
  参考文献：
  名称：

  Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase

  摘要：

  Members of three classes of pyridinylimidazoles bind with varying affinities to CSBP (p38) kinase which is a member of a stress-induced signal transduction pathway. Based upon SAR and protein homology modeling, the pharmacophore and three potential modes of binding to the enzyme are presented. For a subset of pyridinylimidazoles, binding is shown to correlate with inhibition of CSBP kinase activity, whereas no significant inhibition of PKA, PKC alpha and ERK kinase activity is observed. Copyright (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0968-0896(96)00212-x

文献信息

• Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
  申请人：SMITHKLINE BEECHAM CORPORATION

  公开号：EP0306300A2

  公开（公告）日：1989-03-08

  Compounds comprising pyridyl and phenyl substituted pyrrolo[1,2-a]imidazole derivatives and pyridyl and phenyl substituted imidazo[1,2-a]pyridine derivatives, of formula wherein n = 0 or 1, and their use as 5-lipoxygenase pathway inhibitors.

  由吡啶基和苯基取代的吡咯并[1,2-a]咪唑衍生物和吡啶基和苯基取代的咪唑并[1,2-a]吡啶衍生物组成的化合物，其式为 其中 n = 0 或 1，以及它们作为 5-脂氧合酶途径抑制剂的用途。
• Pyrrolo[1,2-a]imidazole and imidazo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
  申请人：SMITHKLINE BEECHAM CORPORATION

  公开号：EP0364204A1

  公开（公告）日：1990-04-18

  Compounds of formula (I) in which one of R or R1 must be alkylsubstituted pyridyl, processes for their preparation, compositions containing them and their use as inhibitors of 5-lipoxygenase.

  式 (I) 的化合物 其中 R 或 R1 之一必须是烷基取代的吡啶基、其制备工艺、含有它们的组合物以及它们作为 5-脂氧合酶抑制剂的用途。
• BENDER, PAUL E.;HANNA, NABIL
  作者：BENDER, PAUL E.、HANNA, NABIL

  DOI：——

  日期：——
• Inhibition of the 5-lipoxygenase pathway
  申请人：SMITHKLINE BEECHAM CORPORATION

  公开号：EP0231622B1

  公开（公告）日：1994-08-24
• US4719218A
  申请人：——

  公开号：US4719218A

  公开（公告）日：1988-01-12